EUVIMEDEUVIMED entdecken
Fallbericht

Diffuse midline glioma, H3K27-altered: a rare presentation with gliomatosis cerebri growth pattern and progression toward midline

Masahiro Uchimura, Asuka Araki, Hirotake Eda, Yoriyoshi Kimura, Kentaro Hayashi

Brain Tumor Pathology · 2026

DOI: 10.1007/s10014-025-00515-1 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Brain Tumor Pathology, 2026. Verfasst von Masahiro Uchimura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, NHO Hamada Medical Center, 777-12 Asai-cho, Hamada-shi, Shimane, 697-0022, Japan. m_u.8953@med.shimane-u.ac.jp. Hauptthemen laut MEDLINE: Brain Neoplasms, Brain Stem Neoplasms, Glioma, Histones. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A limited number of cases involving non-midline lesions have been documented in diffuse midline glioma (DMG), H3K27-altered, for which a definitive classification has yet to be developed. Additionally, no studies have investigated the temporal evolution of imaging features in diffuse non-midline gliomas. We herein report a case of DMG, H3K27-altered, initially presenting with a gliomatosis cerebri-like appearance, cystic lesions in the right frontal lobe, and progression toward the brainstem. Histopathological analysis and comprehensive genomic profiling indicated glioblastoma (GBM) or DMG, H3K27-altered. The patient was diagnosed with GBM because of imaging characteristics atypical for DMG; however, 9 months after the initial diagnosis, a pontine glioma emerged. This case indicates that DMG, H3K27-altered, may exhibit atypical characteristics, including non-midline cystic lesions, that can subsequently progress to pontine gliomas. Considering the limited therapeutic options available for this malignancy, the early recognition of such atypical presentations is crucial for achieving a timely and accurate diagnosis of DMG, H3K27-altered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsBrain Stem NeoplasmsGliomaHistonesNeoplasms, NeuroepithelialHumansDisease ProgressionGlioblastomaMagnetic Resonance Imaging

Stichwörter der Autor:innen

Cystic lesionDiffuse midline gliomaDiffuse non-midline gliomaGliomatosis cerebriH3K27-altered

Substanzen

Histones

Autor:innen und Institutionen

  • Department of Neurosurgery, NHO Hamada Medical Center, 777-12 Asai-cho, Hamada-shi, Shimane, 697-0022, Japan. m_u.8953@med.shimane-u.ac.jp.
  • Department of Neurosurgery, Shimane University Faculty of Medicine, Izumo, Shimane, Japan. m_u.8953@med.shimane-u.ac.jp.
  • Department of Pathology, University Hospital, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.
  • Department of Neurosurgery, NHO Hamada Medical Center, 777-12 Asai-cho, Hamada-shi, Shimane, 697-0022, Japan.
  • Department of Neurosurgery, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.

Zitieren

APA

Uchimura, M., Araki, A., Eda, H., Kimura, Y., & Hayashi, K. (2026). Diffuse midline glioma, H3K27-altered: a rare presentation with gliomatosis cerebri growth pattern and progression toward midline. Brain Tumor Pathology. https://doi.org/10.1007/s10014-025-00515-1

Vancouver

Uchimura M, Araki A, Eda H, Kimura Y, Hayashi K. Diffuse midline glioma, H3K27-altered: a rare presentation with gliomatosis cerebri growth pattern and progression toward midline. Brain Tumor Pathology. 2026. doi:10.1007/s10014-025-00515-1

BibTeX
@article{Uchimura2026,
  author = {Uchimura, Masahiro and Araki, Asuka and Eda, Hirotake and Kimura, Yoriyoshi and Hayashi, Kentaro},
  title = {Diffuse midline glioma, H3K27-altered: a rare presentation with gliomatosis cerebri growth pattern and progression toward midline},
  journal = {Brain Tumor Pathology},
  year = {2026},
  doi = {10.1007/s10014-025-00515-1}
}
Kostenlos starten →